List of PET radiotracers

From WikiMD's WELLNESSPEDIA

PET Radiotracers are chemical compounds that are used in the medical imaging technique known as Positron Emission Tomography (PET). These radiotracers are typically injected into the bloodstream, inhaled or swallowed, and they emit positrons that can be detected by the PET scanner to create detailed images of the body's internal structures and functions.

Types of PET Radiotracers[edit]

There are several types of PET radiotracers, each with its own specific uses and characteristics.

Fluorodeoxyglucose (FDG)[edit]

Fluorodeoxyglucose (FDG) is the most commonly used PET radiotracer. It is a glucose analog that is taken up by cells and trapped in the cell when it is phosphorylated by hexokinase, the first enzyme in the glycolysis pathway. FDG is used to image glucose metabolism, which is increased in many types of cancer cells.

Fluorodopa (FDOPA)[edit]

Fluorodopa (FDOPA) is a radiotracer used to image the dopamine system in the brain. It is used in the diagnosis and monitoring of Parkinson's disease and other disorders of the dopaminergic system.

Fluoromisonidazole (FMISO)[edit]

Fluoromisonidazole (FMISO) is a radiotracer used to image hypoxia, or low oxygen levels, in tissues. This can be useful in the diagnosis and monitoring of certain types of cancer, as hypoxic cells are often more resistant to radiation therapy.

Choline C-11[edit]

Choline C-11 is a radiotracer used to image cell proliferation, as choline is a component of the cell membrane. It is used in the diagnosis and monitoring of prostate cancer.

Applications[edit]

PET radiotracers are used in a wide range of medical applications, including:

  • Oncology: PET scans using FDG can detect cancer, determine the stage of the cancer, assess the effectiveness of treatment, and detect any recurrence of the cancer.
  • Neurology: PET scans using FDOPA can detect changes in the brain's dopamine system, which can be useful in the diagnosis and monitoring of Parkinson's disease and other neurological disorders.
  • Cardiology: PET scans can assess blood flow to the heart, determine the effects of a heart attack, and assess the effectiveness of treatment.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.